ICU Medical Analyst Price Targets - Benzinga

ICU Medical Inc

ICUINASDAQ

Trade with Public

Trade with Public

$160.51

-2.93-1.79%

Últ. Act.: Sep 30, 4:04 PM

$161.21

-2.23-1.36%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

ICU Medical Analyst Price Targets - Benzinga

ICU Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for ICU Medical (ICUI).

Price Target Range — 12 Quarters

Analyst Consensus — 7 Analysts

1S.Buy

6Buy

Consensus RatingBuy# Analysts7Avg. Consensus PT$181Upside to Avg. PT+12.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	Piper Sandler	Jason Bednar	PT Raise	Overweight	$163→$195
Aug 7, 2026	BTIG	Sam Eiber	PT Raise	Buy	$170→$200
Aug 7, 2026	Needham	Mike Matson	PT Raise	Buy	$165→$187
Jul 21, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$164→$182
Jun 15, 2026	BTIG	Sam Eiber	Initiate	Buy	$170
May 27, 2026	Needham	Mike Matson	Upgrade	Hold→Buy	$165
Apr 27, 2026	Keybanc	Brett Fishbin	PT Cut	Overweight	$180→$164
Apr 17, 2026	Piper Sandler	Jason Bednar	PT Cut	Overweight	$178→$163
Feb 20, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$175→$180
Feb 20, 2026	Piper Sandler	Jason Bednar	PT Raise	Overweight	$172→$178
Nov 7, 2025	Keybanc	Brett Fishbin	PT Raise	Overweight	$173→$175
Nov 7, 2025	Piper Sandler	Jason Bednar	PT Raise	Overweight	$153→$172
Oct 21, 2025	Keybanc	Brett Fishbin	PT Cut	Overweight	$191→$173
Sep 10, 2025	Piper Sandler	Jason Bednar	PT Raise	Overweight	$145→$153
Aug 15, 2025	Piper Sandler	Jason Bednar	Initiate	Overweight	$145
Aug 8, 2025	Raymond James	Jayson Bedford	PT Cut	Strong Buy	$187→$180
May 9, 2025	Raymond James	Jayson Bedford	PT Cut	Strong Buy	$197→$187
Apr 21, 2025	Keybanc	Tim Rezvan	PT Cut	Overweight	$209→$191
Apr 8, 2025	Needham	Mike Matson	Maintained	Hold	—
Mar 12, 2025	Raymond James	Jayson Bedford	PT Cut	Outperform→Strong Buy	$205→$197

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $195

Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $163 to $195.

Benzinga Newsdesk

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.

Avi Kapoor

PRO
BTIG Maintains Buy on ICU Medical, Raises Price Target to $200

BTIG analyst Sam Eiber maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $170 to $200.

Benzinga Newsdesk

PRO
Needham Maintains Buy on ICU Medical, Raises Price Target to $187

Needham analyst Mike Matson maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $165 to $187.

Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $182

Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $164 to $182.

Benzinga Newsdesk

This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's analyst ratings page. See analyst views on ICUI, BDSX,.

Avi Kapoor